Literature DB >> 6020628

Late elevation in serum bromsulfalein in Dubin-Johnson syndrome. A comparative case study.

M R Dollinger, L L Brandborg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6020628     DOI： 10.1007/bf02241946

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN： 0002-9211


× No keyword cloud information.
  8 in total

1.  HEPATITIS WITH RESULTING MOBILIZATION OF HEPATIC PIGMENT IN A PATIENT WITH DUBIN-JOHNSON SYNDROME.

Authors:  F M HUNTER; R D SPARKS; R L FLINNER
Journal:  Gastroenterology       Date:  1964-12       Impact factor: 22.682

2.  SULFOBROMOPHTHALEIN TRANSPORT AND METABOLISM.

Authors:  L J SCHOENFIELD
Journal:  Gastroenterology       Date:  1965-04       Impact factor: 22.682

3.  Studies of chronic familial non-hemolytic jaundice with conjugated bilirubin in the serum with and without an unidentified pigment in the liver cells.

Authors:  I M ARIAS
Journal:  Am J Med       Date:  1961-10       Impact factor: 4.965

4.  Effect of hepatic dysfunction on circulating levels of sulfobromophthalein and its metabolites.

Authors:  J V CARBONE; G M GRODSKY; V HJELTE
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

5.  Familial chronic idiopathic jaundice (Dubin-Sprinz disease), with a note on bromsulphalein metabolism in this disease.

Authors:  E MANDEMA; W de FRAITURE; H O NIEWEG; A ARENDS
Journal:  Am J Med       Date:  1960-01       Impact factor: 4.965

6.  The distribution and excretion of S35-labeled sulfobromophthalein-sodium administered to dogs by continuous infusion.

Authors:  R W BRAUER; R L PESSOTTI; J S KREBS
Journal:  J Clin Invest       Date:  1955-01       Impact factor: 14.808

7.  Chronic idiopathic jaundice with unidentified pigment in liver cells; a new clinicopathologic entity with a report of 12 cases.

Authors:  I N DUBIN; F B JOHNSON
Journal:  Medicine (Baltimore)       Date:  1954-09       Impact factor: 1.889

8.  Biliary transport and hepatic storage of sulfobromophthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease.

Authors:  H O WHEELER; J I MELTZER; S E BRADLEY
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808
  8 in total
  3 in total

Review 1.  New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias.

Authors:  P Berthelot; D Dhumeaux
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

2.  Metabolism of the bromsulphalein in Dubin-Johnson syndrome. Diagnostic value of the paradoxical increase in plasma levels at BSP.

Authors:  J Rodes; A Zubizarreta; M Bruguera
Journal:  Am J Dig Dis       Date:  1972-06

3.  Clinicopathological studies of the Dubin-Johnson syndrome complicated with chronic hepatitis.

Authors:  S Watanabe; M Nishioka; T Kodama; K Ando; Y Numa; Y Fukumoto; K Okita; T Takemoto; M Mizuta
Journal:  Gastroenterol Jpn       Date:  1982-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.